Genenta Science SPA (FRA:K5F) Days Payable : 0.00 (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Genenta Science SPA Days Payable?

Genenta Science SPA's average Accounts Payable for the six months ended in Jun. 2024 was €0.35 Mil. Genenta Science SPA's Cost of Goods Sold for the six months ended in Jun. 2024 was €0.00 Mil.

The historical rank and industry rank for Genenta Science SPA's Days Payable or its related term are showing as below:

FRA:K5F's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 127.14
* Ranked among companies with meaningful Days Payable only.

Genenta Science SPA's Days Payable stayed the same from Jun. 2023 (0.00) to Jun. 2024 (0.00).

Genenta Science SPA Days Payable Historical Data

The historical data trend for Genenta Science SPA's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genenta Science SPA Days Payable Chart

Genenta Science SPA Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Genenta Science SPA Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Days Payable	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of Genenta Science SPA's Days Payable

For the Biotechnology subindustry, Genenta Science SPA's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genenta Science SPA's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genenta Science SPA's Days Payable distribution charts can be found below:

* The bar in red indicates where Genenta Science SPA's Days Payable falls into.

Genenta Science SPA Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Genenta Science SPA's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (1.042	+	0.295)	/	2 )	/	0	*	365
=	0.6685					/	0	*	365
=	N/A

Genenta Science SPA's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

	Days Payable (Q: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2023 )	+	Accounts Payable (Q: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2024 )	*	Days in Period
=	( (0.295	+	0.406)	/	2 )	/	0	*	365 / 2
=	0.3505					/	0	*	365 / 2
=	N/A

Genenta Science SPA Days Payable Related Terms

Thank you for viewing the detailed overview of Genenta Science SPA's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Genenta Science SPA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genenta Science SPA (FRA:K5F) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

GNTA:USA

Address

Via Olgettina No. 58, Milan, ITA, 20132

Website

https://www.genenta.com

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.

Genenta Science SPA Headlines

No Headlines